Kazia Therapeutics (KZIA) Dividends payables (2013)
Kazia Therapeutics' (KZIA) quarterly Dividends payables came in at -$22985.3 billion in Q4 2013.
Kazia Therapeutics (KZIA) Dividends payables (2013) Analysis & Trends
Kazia Therapeutics (KZIA) has 1 years of Dividends payables data on file, last reported at -$22985.3 billion in Q4 2013.
- Quarterly Dividends payables changed N/A year-over-year to -$22985.3 billion in Q4 2013, while the trailing twelve-month figure through Dec 2013 was -$22985.3 billion (changed N/A YoY) and the FY2013 annual result came in at -$24002.8 billion, changed N/A from the prior year.
- Dividends payables held at -$22985.3 billion in Q4 2013.
- In the past five years, Dividends payables ranged from a high of -$22985.3 billion in Q4 2013 to a low of -$22985.3 billion in Q4 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Kazia Therapeutics | 4.22 Bn | 4.22 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2013 | -22,985.27 Bn |